JPRN-UMIN000038558已完成4 期
The impact of pemafibrate on dyslipidemia in patients with severe adult growth hormone deficiency: A prospective cohort study. - The impact of pemafibrate on dyslipidemia in patients with severe adult growth hormone deficiency: A prospective cohort study.
TT EAST SAPPORO HOSPITA0 个研究点目标入组 34 人开始时间: 2019年11月12日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments
研究者
相似试验
已完成
4 期
The impact of pemafibrate on hypertriglyceridemia in patients with type 2 diabetes: A prospective cohort study.dyslipidemiJPRN-UMIN000037385Hokkaido University Hospital650
招募中
不适用
Effect of pemafibrate on lipid and bile acid metabolism in patients with fatty liver or primary biliary cholangitisfatty liver, PBCJPRN-UMIN000039125Tokai University School of Medicine80
已完成
不适用
PARADISE in Kagoshima studyhyperlipidemia, Type 2 Diabetes MellitusJPRN-jRCTs071190049ishio Yoshihiko100
尚未招募
不适用
Clinical benefit of pemafibrate in patients with primary biliary cholangitis (PBC) with dyslipidemiaprimary biliary cholangitisJPRN-UMIN000039350Shinshu University Faculty of Medicine, Department of Gastroenterology60
已完成
不适用
Investigation for the effect of anti-dyslipidemic drugs on serum level of trans-fatty acidsdyslipidemiaJPRN-UMIN000026984Kobe University Graduate School of Medicine40